Predictive model for prognosis, immune microenvironment and drug sensitivity of colon carcinoma based on cuproptosis-related genes

Colon cancer is a major cause of morbidity and mortality worldwide. Copper-induced cell death, known as cuproptosis, is a form of apoptosis that has been extensively studied in human diseases and is widely associated with tumor progression, prognosis, and immune response. However, the role of cuprop...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:International journal of clinical and experimental pathology Ročník 18; číslo 4; s. 148
Hlavní autoři: Zhao, Bo, Lu, Wenqi, Chen, Yongjun, Cai, Xiaoyong
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States 01.01.2025
Témata:
ISSN:1936-2625, 1936-2625
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Colon cancer is a major cause of morbidity and mortality worldwide. Copper-induced cell death, known as cuproptosis, is a form of apoptosis that has been extensively studied in human diseases and is widely associated with tumor progression, prognosis, and immune response. However, the role of cuproptosis-related genes (CRGs) in the tumor microenvironment (TME) of colon cancer remains unclear. This study aims to explore the role of cuproptosis-related long non-coding RNAs (lncRNAs) in predicting the prognosis of colon cancer and to establish a risk prediction model based on these lncRNAs to guide clinical decisions and improve patient outcomes. A total of 19 cuproptosis-related genes were collected, and 1330 lncRNAs associated with cuproptosis were identified. Seven cuproptosis-related lncRNAs with prognostic value were selected from The Cancer Genome Atlas (TCGA) database. Using R software (version 4.1.0), the expression levels of the 19 genes were extracted, and the subjects were divided into high- and low-risk subgroups. A risk score model was developed based on cuproptosis-related genes and the seven co-expressed lncRNAs. The dataset was randomly split into a training set and a validation set. Analysis of clinicopathologic features, TME infiltration, and mutations was conducted, and nomogram predictions were validated using calibration plots to assess the predictive accuracy of the model. The high-risk group had significantly shorter overall survival compared to the low-risk group (P<0.001), and the risk score was an independent prognostic factor (P<0.001). In the training set, the AUC values at 1, 3, and 5 years were 0.666, 0.621, and 0.669, respectively. Furthermore, low-risk patients had a higher survival rate. The genetic markers also correlated with tumor immune cell infiltration, clinical features, and prognosis. This study established a novel method based on cuproptosis-related lncRNAs to predict the prognosis of colon cancer. The model has potential clinical applications in identifying patients sensitive to immunotherapy and antitumor treatments, thereby enhancing precision treatment strategies for colon cancer.
AbstractList Colon cancer is a major cause of morbidity and mortality worldwide. Copper-induced cell death, known as cuproptosis, is a form of apoptosis that has been extensively studied in human diseases and is widely associated with tumor progression, prognosis, and immune response. However, the role of cuproptosis-related genes (CRGs) in the tumor microenvironment (TME) of colon cancer remains unclear.BACKGROUNDColon cancer is a major cause of morbidity and mortality worldwide. Copper-induced cell death, known as cuproptosis, is a form of apoptosis that has been extensively studied in human diseases and is widely associated with tumor progression, prognosis, and immune response. However, the role of cuproptosis-related genes (CRGs) in the tumor microenvironment (TME) of colon cancer remains unclear.This study aims to explore the role of cuproptosis-related long non-coding RNAs (lncRNAs) in predicting the prognosis of colon cancer and to establish a risk prediction model based on these lncRNAs to guide clinical decisions and improve patient outcomes.OBJECTIVEThis study aims to explore the role of cuproptosis-related long non-coding RNAs (lncRNAs) in predicting the prognosis of colon cancer and to establish a risk prediction model based on these lncRNAs to guide clinical decisions and improve patient outcomes.A total of 19 cuproptosis-related genes were collected, and 1330 lncRNAs associated with cuproptosis were identified. Seven cuproptosis-related lncRNAs with prognostic value were selected from The Cancer Genome Atlas (TCGA) database. Using R software (version 4.1.0), the expression levels of the 19 genes were extracted, and the subjects were divided into high- and low-risk subgroups. A risk score model was developed based on cuproptosis-related genes and the seven co-expressed lncRNAs. The dataset was randomly split into a training set and a validation set. Analysis of clinicopathologic features, TME infiltration, and mutations was conducted, and nomogram predictions were validated using calibration plots to assess the predictive accuracy of the model.METHODSA total of 19 cuproptosis-related genes were collected, and 1330 lncRNAs associated with cuproptosis were identified. Seven cuproptosis-related lncRNAs with prognostic value were selected from The Cancer Genome Atlas (TCGA) database. Using R software (version 4.1.0), the expression levels of the 19 genes were extracted, and the subjects were divided into high- and low-risk subgroups. A risk score model was developed based on cuproptosis-related genes and the seven co-expressed lncRNAs. The dataset was randomly split into a training set and a validation set. Analysis of clinicopathologic features, TME infiltration, and mutations was conducted, and nomogram predictions were validated using calibration plots to assess the predictive accuracy of the model.The high-risk group had significantly shorter overall survival compared to the low-risk group (P<0.001), and the risk score was an independent prognostic factor (P<0.001). In the training set, the AUC values at 1, 3, and 5 years were 0.666, 0.621, and 0.669, respectively. Furthermore, low-risk patients had a higher survival rate. The genetic markers also correlated with tumor immune cell infiltration, clinical features, and prognosis.RESULTSThe high-risk group had significantly shorter overall survival compared to the low-risk group (P<0.001), and the risk score was an independent prognostic factor (P<0.001). In the training set, the AUC values at 1, 3, and 5 years were 0.666, 0.621, and 0.669, respectively. Furthermore, low-risk patients had a higher survival rate. The genetic markers also correlated with tumor immune cell infiltration, clinical features, and prognosis.This study established a novel method based on cuproptosis-related lncRNAs to predict the prognosis of colon cancer. The model has potential clinical applications in identifying patients sensitive to immunotherapy and antitumor treatments, thereby enhancing precision treatment strategies for colon cancer.CONCLUSIONThis study established a novel method based on cuproptosis-related lncRNAs to predict the prognosis of colon cancer. The model has potential clinical applications in identifying patients sensitive to immunotherapy and antitumor treatments, thereby enhancing precision treatment strategies for colon cancer.
Colon cancer is a major cause of morbidity and mortality worldwide. Copper-induced cell death, known as cuproptosis, is a form of apoptosis that has been extensively studied in human diseases and is widely associated with tumor progression, prognosis, and immune response. However, the role of cuproptosis-related genes (CRGs) in the tumor microenvironment (TME) of colon cancer remains unclear. This study aims to explore the role of cuproptosis-related long non-coding RNAs (lncRNAs) in predicting the prognosis of colon cancer and to establish a risk prediction model based on these lncRNAs to guide clinical decisions and improve patient outcomes. A total of 19 cuproptosis-related genes were collected, and 1330 lncRNAs associated with cuproptosis were identified. Seven cuproptosis-related lncRNAs with prognostic value were selected from The Cancer Genome Atlas (TCGA) database. Using R software (version 4.1.0), the expression levels of the 19 genes were extracted, and the subjects were divided into high- and low-risk subgroups. A risk score model was developed based on cuproptosis-related genes and the seven co-expressed lncRNAs. The dataset was randomly split into a training set and a validation set. Analysis of clinicopathologic features, TME infiltration, and mutations was conducted, and nomogram predictions were validated using calibration plots to assess the predictive accuracy of the model. The high-risk group had significantly shorter overall survival compared to the low-risk group (P<0.001), and the risk score was an independent prognostic factor (P<0.001). In the training set, the AUC values at 1, 3, and 5 years were 0.666, 0.621, and 0.669, respectively. Furthermore, low-risk patients had a higher survival rate. The genetic markers also correlated with tumor immune cell infiltration, clinical features, and prognosis. This study established a novel method based on cuproptosis-related lncRNAs to predict the prognosis of colon cancer. The model has potential clinical applications in identifying patients sensitive to immunotherapy and antitumor treatments, thereby enhancing precision treatment strategies for colon cancer.
Author Chen, Yongjun
Cai, Xiaoyong
Lu, Wenqi
Zhao, Bo
Author_xml – sequence: 1
  givenname: Bo
  surname: Zhao
  fullname: Zhao, Bo
  organization: Department of General Surgery, The Second Affiliated Hospital of Guangxi Medical University Nanning 530021, Guangxi Zhuang Autonomous Region, The People's Republic of China
– sequence: 2
  givenname: Wenqi
  surname: Lu
  fullname: Lu, Wenqi
  organization: Department of General Surgery, The Second Affiliated Hospital of Guangxi Medical University Nanning 530021, Guangxi Zhuang Autonomous Region, The People's Republic of China
– sequence: 3
  givenname: Yongjun
  surname: Chen
  fullname: Chen, Yongjun
  organization: Department of General Surgery, The Second Affiliated Hospital of Guangxi Medical University Nanning 530021, Guangxi Zhuang Autonomous Region, The People's Republic of China
– sequence: 4
  givenname: Xiaoyong
  surname: Cai
  fullname: Cai, Xiaoyong
  organization: Department of General Surgery, The Second Affiliated Hospital of Guangxi Medical University Nanning 530021, Guangxi Zhuang Autonomous Region, The People's Republic of China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40371092$$D View this record in MEDLINE/PubMed
BookMark eNpNkE9LAzEQxYNU7B89-AUkRw-uZpM02z1KaVUo6EHPSzaZlMgmqcluoVc_uSlWcC4zvHnz4zFTNPLBA0LXJbkXlPHqYb1arUu-YGdoUtZMFFTQ-ejfPEbTlD4JESXl5AKNOWFVSWo6Qd9vEbRVvd0DdkFDh02IeBfD1odk0x22zg0-76yKAfzexuAd-B5Lr7GOwxYn8Mnme9sfcDBYhS54rGRU1gcncSsTaHyUhkzd9UdqEaGTfZa34CFdonMjuwRXpz5DH-vV-_K52Lw-vSwfN4WiQvSF4aJt5yXVjHDGc80XRBgxZ6ziumZUV0qzWldVK6ThpVJGVTUzrWnbbCZAZ-j2l5tzfA2Q-sbZpKDrpIcwpIbRDGa8rHi23pysQ-tAN7tonYyH5u9v9AdHI3Lp
ContentType Journal Article
Copyright IJCEP Copyright © 2025.
Copyright_xml – notice: IJCEP Copyright © 2025.
DBID NPM
7X8
DOI 10.62347/FEEF1483
DatabaseName PubMed
MEDLINE - Academic
DatabaseTitle PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1936-2625
ExternalDocumentID 40371092
Genre Journal Article
GroupedDBID ---
2WC
53G
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
BAWUL
C1A
DIK
HYE
NPM
OK1
RPM
TR2
7X8
ID FETCH-LOGICAL-c266t-f46bb512d304344445806f653374d932d7cd39d77b6af41ccfc793fbfbb4440e2
IEDL.DBID 7X8
ISICitedReferencesCount 0
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001479808200002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1936-2625
IngestDate Fri May 16 03:23:10 EDT 2025
Sat May 17 01:30:41 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 4
Keywords colon carcinoma
tumor microenvironment
LncRNA prognostic model
Cuproptosis
Language English
License IJCEP Copyright © 2025.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c266t-f46bb512d304344445806f653374d932d7cd39d77b6af41ccfc793fbfbb4440e2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doi.org/10.62347/feef1483
PMID 40371092
PQID 3204334174
PQPubID 23479
ParticipantIDs proquest_miscellaneous_3204334174
pubmed_primary_40371092
PublicationCentury 2000
PublicationDate 2025-01-01
PublicationDateYYYYMMDD 2025-01-01
PublicationDate_xml – month: 01
  year: 2025
  text: 2025-01-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle International journal of clinical and experimental pathology
PublicationTitleAlternate Int J Clin Exp Pathol
PublicationYear 2025
SSID ssj0061240
Score 2.3603976
Snippet Colon cancer is a major cause of morbidity and mortality worldwide. Copper-induced cell death, known as cuproptosis, is a form of apoptosis that has been...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 148
Title Predictive model for prognosis, immune microenvironment and drug sensitivity of colon carcinoma based on cuproptosis-related genes
URI https://www.ncbi.nlm.nih.gov/pubmed/40371092
https://www.proquest.com/docview/3204334174
Volume 18
WOSCitedRecordID wos001479808200002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT4NAEN6oNcaL70d9ZU08uilltyycjDElHmzTgya9EfbV9OBSS-sP8Jc7A1S9mJjIgZAFNrAMM9_uPD5CboTKsawYTHKcChhYaNCDNuoyYyMTx1rlwlZ1Zp_kcBiPx8moWXArm7DKlU6sFLUpNK6RdzgmcYLKleJu9saQNQq9qw2FxjppcYAyKNVy_OVFAONdJ0QmPGIhAP26shAYfCE7ab-fwlSA_44sKwuT7v732fbIToMt6X0tDPtkzfoDsjVovOeH5GM0x2NUcLRiwKGAWClGaPminJa3dIrJInAOg_R-ZMDR3Btq5ssJLTHcveaboIWjWPHaU410RL54zSmaREOxaQm9zhbYK6uyZaB5glr1iLyk_eeHR9ZwMDANpnvBnIiUAlBgOLyigK0XB5GLACRKYQD7GakNT4yUKsqd6GrtNPzxTjml4OLAhsdkwxfenhJqROB6IUiAAxiUxC52XErX5bGC3qXotcn1anQzkHF0XOTeFssy-x7fNjmpP1E2q4txZAJrDgZJePaHu8_Jdoj0vdUKygVpOfjD7SXZ1O-LaTm_qoQH9sPR4BPWW9F0
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Predictive+model+for+prognosis%2C+immune+microenvironment+and+drug+sensitivity+of+colon+carcinoma+based+on+cuproptosis-related+genes&rft.jtitle=International+journal+of+clinical+and+experimental+pathology&rft.au=Zhao%2C+Bo&rft.au=Lu%2C+Wenqi&rft.au=Chen%2C+Yongjun&rft.au=Cai%2C+Xiaoyong&rft.date=2025-01-01&rft.eissn=1936-2625&rft.volume=18&rft.issue=4&rft.spage=148&rft_id=info:doi/10.62347%2FFEEF1483&rft_id=info%3Apmid%2F40371092&rft_id=info%3Apmid%2F40371092&rft.externalDocID=40371092
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1936-2625&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1936-2625&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1936-2625&client=summon